Skip to main content
Year archive

Prism Medico and Pharmacy Ltd. — 2020 filings

All 62 regulatory filings released by Prism Medico and Pharmacy Ltd. (512217) in 2020, sourced directly from the official regulator.

62 Filings
2020 Period
2020 filings (62)
Filing Released Lang
In this regards, we are enclosing herewith Financial results for the quarter ended 30th September 2020 as per IND-AS format and Cash Flow statement.
Regulatory Filings
2020-12-04 English
In this regards, we are enclosing herewith Financial results for the quarter ended 30th September 2020 as per IND-AS format and Cash Flow statement.
Regulatory Filings
2020-12-04 English
Pursuant to Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we inform you that the Company has received a letter from Mrs. Charu Pareek, tendering ....
Regulatory Filings
2020-11-11 English
Pursuant to the Regulation 33 of the SEBI (LODR) Regulations, 2015, the Board of Directors of the Company at their meeting held on 10/11/2020 at the Registered Office of the company have ....
Regulatory Filings
2020-11-10 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, 10th November 2020 at 03.00 p.m concluded ....
Regulatory Filings
2020-11-10 English
This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company is ....
Regulatory Filings
2020-11-03 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve 1.To consider and ....
Regulatory Filings
2020-11-02 English
We hereby furnish a copy of Compliance Certificate issued by M.R. Chechi & Associates, Practicing Company Secretaries, Chandigarh.
Regulatory Filings
2020-10-16 English
Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby submit a certificate duly signed by Purva Sharegistry (I) Pvt Ltd, Share ....
Regulatory Filings
2020-10-12 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a revised copy of Confirmation Certificate issued ....
Regulatory Filings
2020-10-12 English
We hereby furnish a copy of Confirmation Certificate issued by the RTA, Purva Sharegistry (I) Pvt Limited.
Regulatory Filings
2020-10-09 English
Trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter ended 30th September, 2020 for ....
Regulatory Filings
2020-10-01 English
We hereby submit revised Financial Results for the Quarter ended 30th June 2020 as per IND-AS format.
Regulatory Filings
2020-09-12 English
We hereby submit Voting Results of the 18th AGM as per Reg. 44(3) of SEBI(LODR)2015.
Regulatory Filings
2020-09-12 English
We hereby submit consolidated scrutinizer''s report of e-voting of 18th AGM.
Regulatory Filings
2020-09-11 English
Pursuant to regulation 30(2) of SEBI (LODR) regulations 2015, we hereby submit proceedings of 18th Annual General Meeting held on 10th September 2020.
Regulatory Filings
2020-09-10 English
We would like to clarify that due to clerical typing error, day of the meeting was written as Monday instead of Thursday.Revised Notice is attached. You are requested to kindly take the ....
Regulatory Filings
2020-09-01 English
Publication regarding Notice of the 18th Annual General Meeting of the company in `Business Standard'' (English) and `Desh Sewak (Punjabi).
Regulatory Filings
2020-09-01 English
we hereby state that there have been no deviation(s) or Variation(s). Further, company has not raised any funds by way of public issue, right issue, preferential issue, etc. Hence, ....
Regulatory Filings
2020-08-26 English
We hereby enclose a copy of the Annual Report of the Company for the financial year ended 31st March, 2020.
Regulatory Filings
2020-08-18 English
Ccopy of the Notice of the 18th Annual General Meeting of the Company for the financial year ended 31st March, 2020 to be held on Thursday, 10th September 2020, is enclosed with video Conferencing ...
Regulatory Filings
2020-08-18 English
We hereby enclose a copy of the Notice of the 18th Annual General Meeting of the Company for the financial year ended 31st March, 2020 to be held on Thursday, 10th September 2020, through ....
Regulatory Filings
2020-08-18 English
We hereby furnish newspaper publication under Reg. 47 of SEBI (LODR) Regulations, 2015, in respect of approval of un-audited financial results for the quarter June 30, 2020 on 13th August ....
Regulatory Filings
2020-08-18 English
Pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2018, the Register of Member and Share Transfer Books of the Company will remain closed from 4-09-2020 till 10-09-2020 (both days ....
Regulatory Filings
2020-08-14 English
Pursuant to the Regulation 33 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform that the Board of Directors of the Company at their meeting ....
Regulatory Filings
2020-08-13 English
Following transactions were approved: 1.Un-Audited Financial Results for the quarter ended on 30th June 2020. 2.Limited Review Report from the auditor for the quarter ended on 30th June 2020. ....
Regulatory Filings
2020-08-13 English
Newspaper publication of intimation of board meeting to be held on 13th August 2020 to consider and take on record un-audited financial results for the Quarter June 30, 2020 was published ....
Regulatory Filings
2020-08-10 English
Newspaper publication of intimation of board meeting to be held on 13th August 2020 to consider and take on record un-audited financial results for the Quarter June 30, 2020 was published ....
Regulatory Filings
2020-08-10 English
We would like to inform you that the company is not required to file consolidated financial statements for period ended March 2020 as M/s. Healthy Biosciences Private Limited has ceased ....
Regulatory Filings
2020-08-10 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2020 ,inter alia, to consider and approve To consider and ....
Regulatory Filings
2020-08-04 English
The Exchange has received the Revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Paramjeet Kaur
Regulatory Filings
2020-08-01 English
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Paramjeet Kaur
Regulatory Filings
2020-08-01 English
In this regards we are enclosing herewith Cash Flow Statement for the year ended 31st March, 2020.
Regulatory Filings
2020-07-23 English
The Trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter ended 30th June, 2020 for all ....
Regulatory Filings
2020-07-23 English
This is to inform that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company is www.prismmedico.com
Regulatory Filings
2020-07-11 English
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate issued by the RTA, Purva Sharegistry (I) Pvt Limited.
Regulatory Filings
2020-07-06 English
The company have considered and approved the Audited Financial Statements for the quarter and year ended on 31st March, 2020. In this regards, we are enclosing herewith: 1. Audited ....
Regulatory Filings
2020-06-29 English
Following transactions were approved: 1. Audited Standalone Financial Results for the quarter and year ended on 31st March, 2020. 2. Auditors Report on Audited Standalone Financial ....
Regulatory Filings
2020-06-29 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2020 ,inter alia, to consider and approve 1. To approve the ....
Regulatory Filings
2020-06-19 English
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the ....
Regulatory Filings
2020-06-16 English
Trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter and year ended 31st March, 2020 ....
Regulatory Filings
2020-06-15 English
Please find attached Non-Applicability Certificate of SECRETARIAL COMPLIANCE REPORT Provisions under Reg. 24A of SEBI (LODR) 2015.
Regulatory Filings
2020-06-11 English
Kindly note that Mr. Sameer Gupta who is an Associate Member of Institute of Company Secretaries of India (Membership No. -59256) and holds prescribed qualification under Rule 2(1) (Appointment ....
Regulatory Filings
2020-06-08 English
With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Monday, 08th June 2020 at 03.00 p.m approved the following: ...
Regulatory Filings
2020-06-08 English
Dear Sir/Madam, This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website ....
Regulatory Filings
2020-05-22 English
Dear Sir/Madam, This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website ....
Regulatory Filings
2020-05-22 English
Pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby furnish a copy of Compliance Certificate issued by M.R. Chechi & Associates, ....
Regulatory Filings
2020-05-20 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate for Quarter ....
Regulatory Filings
2020-05-19 English
The company has complied with the aforesaid regulations and has maintained all the records of the activities in relation to both physical and electronic share transfer by RTA.
Regulatory Filings
2020-05-09 English
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the ....
Regulatory Filings
2020-03-30 English
Dear Sir/Madam, In reference to your mail dated 11.02.2020, enclosing herewith the revised Standalone and Consolidated Financial Results for the Quarter Ended 31st December, 2019 ....
Regulatory Filings
2020-02-22 English
Dear Sir/Madam, In reference to your mail dated 11.02.2020, enclosing herewith the revised Standalone and Consolidated Financial Results for the Quarter Ended 31st December, 2019 ....
Regulatory Filings
2020-02-22 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Paramjeet Kaur
Regulatory Filings
2020-02-20 English
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the ....
Regulatory Filings
2020-01-30 English
1.Considered and approved the unaudited Standalone and Consolidated Financial Results for the quarter ended 31st December, 2019
Regulatory Filings
2020-01-30 English
Considered and approved the unaudited Standalone and Consolidated Financial Results for the quarter ended 31st December, 2019
Regulatory Filings
2020-01-30 English
1. Pursuant to the resolutions passed at the AGM of the Company. The Board disinvest in the shares of Healthy Biosciences Private Limited. Now, the Company is holding 19.38 % of shares ....
Regulatory Filings
2020-01-27 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2020 ,inter alia, to consider and approve 1.To consider, approve ....
Regulatory Filings
2020-01-22 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve We wish to inform ....
Regulatory Filings
2020-01-18 English
Dear Sir/Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation ....
Regulatory Filings
2020-01-09 English
This has reference with the above mentioned subject, please note that since the Paid Up Equity Share Capital and Net Worth of the Company is less than the prescribed limit, as on ....
Regulatory Filings
2020-01-04 English
This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company ....
Regulatory Filings
2020-01-04 English